Last deal

$4M

Amount

Venture - Series Unknown

Stage

16.07.2010

Date

3

all rounds

$100.9M

Total amount

date founded

Financing round

General

About Company
Surface Logix uses biophysical chemistry to develop new small molecule drugs.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.1999

Number of employees

Company Type

For Profit

Last funding type

Venture - Series Unknown

IPO status

Private

Description

The drug development company Surface Logix specializes in creating small molecule drugs with improved pharmacokinetic and pharmacodynamic properties compared to class leaders. They target tissues and organ systems, including the gastrointestinal tract and cardiovascular systems, to treat metabolic and cardiovascular diseases. Surface Logix also has various programs in other disease areas.
Similar Companies
1000
Origenis

Origenis

Origenis is a small molecule drug discovery company.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Martinsried, 82152 Planegg, Germany
Quercus Molecular Design

Quercus Molecular Design

Quercus Molecular Design is developing small molecule inhibitors to treat infectious diseases and cancer.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Chemical, Health Care

Location

Farmington, CT, USA
Aronora

Aronora

Aronora develops safer biologic drugs.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Portland, OR, USA

total rounds

1
Virobay

Virobay

Virobay develops antiviral drugs for autoimmune diseases, neuropathic pain, liver diseases, and cancer.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Biopharma

Location

Menlo Park, CA, USA

total rounds

4

total raised

$23.77M
M&A Details
1

Transaction name

Acquired by

Nano Terra

announced date

12.04.2011

Financials

Funding Rounds
6
3

Number of Funding Rounds

$100.9M

Money Raised

Their latest funding was raised on 16.07.2010. Their latest round Venture - Series Unknown

Date 
Funding Round 
Investors 
Money Raised 
Lead 
16.07.2010
$4M
09.03.2009
1
$5M
09.03.2009
7
$15M
Co-Investors
Investors
10
2

Number of lead investors

10

Number of investors

Investor 
Lead 
Round 
Partners 
Yes
Series C, Series D, Venture - Series Unknown
Yes
Series D, Series E
No
Series E
CW Ventures

CW Ventures

CW Group is a leading manager of medical venture capital funds focused on seed and early stage healthcare investing.

Sector

Closed End Investments

Subsector

Closed End Investments

Keywords

Venture Capital, Financial Services, Health Care

Location

New York, NY, USA

count Of Investments

8

count Of Exists

3
ARCH Venture Partners

ARCH Venture Partners

ARCH Venture Partners is a venture capital firm that specializes in investing in early-stage technology companies in the United States.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Location

Chicago, IL, USA

count Of Investments

357

count Of Exists

61
Unilever Ventures

Unilever Ventures

Unilever Ventures invests in promising companies in Personal Care and Digital sectors.

Sector

Closed End Investments

Subsector

Closed End Investments

Location

London, UK

count Of Investments

122

count Of Exists

17

People

Employee Profiles
5
Karen Adams

Karen Adams

Team Member

Keith Dionne

Keith Dionne

CEO

Evan Hirsch

Lead Designer

Activity

Recent News
0